Achyut Healthcar

{
  "main_header": {
    "sid": 1003624,
    "name": "Achyut Healthcar",
    "stock_name": "Achyut Healthcar",
    "full_name": "Achyut Healthcare Ltd",
    "name_url": "stocks-analysis/achyut-healthcar",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "5.90",
    "chg": 0.12,
    "chgp": "2.08%",
    "dir": 1,
    "prev_price": "5.78",
    "mcapval": "141.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543499,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 49,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE0K1401020",
    "curr_date": "Jun 03, 03:30 PM",
    "curr_time": "22:39 PM",
    "last_traded_at": "Jun 03, 03:30 PM IST",
    "bse_nse_vol": 94125,
    "exc_status": "Active",
    "traded_date": "Jun 03, 2026",
    "traded_date_str": "2026 06 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/achyut-healthcar-1003624-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Achyut Healthcare Ltd Upgraded to Sell on Improved Quality and Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/achyut-healthcare-ltd-upgraded-to-sell-on-improved-quality-and-valuation-concerns-4025615",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AchyutHealthcar_mojoScore_4025615.png",
        "date": "2026-06-01 08:27:02",
        "description": "Achyut Healthcare Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 29 May 2026, reflecting a notable improvement in its quality metrics despite persistent concerns over its valuation and financial trends. The micro-cap pharmaceutical and biotechnology company’s Mojo Score has risen to 35.0, signalling a cautious but more favourable outlook amid mixed fundamentals and technical signals."
      },
      {
        "title": "Achyut Healthcare Ltd Valuation Shifts Signal Elevated Price Risk",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/achyut-healthcare-ltd-valuation-shifts-signal-elevated-price-risk-4025501",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AchyutHealthcar_valuationdot_4025501.png",
        "date": "2026-06-01 08:07:15",
        "description": "Achyut Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a marked shift in its valuation parameters, moving from a risky to a very expensive valuation grade. Despite a modest price appreciation, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios have surged well above peer averages and historical norms, raising concerns about price attractiveness for investors."
      },
      {
        "title": "Achyut Healthcare Ltd Quality Grade Upgrade Signals Improving Fundamentals Amid Mixed Financial Metrics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/achyut-healthcare-ltd-quality-grade-upgrade-signals-improving-fundamentals-amid-mixed-financial-metrics-4025115",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AchyutHealthcar_qualitydot_4025115.png",
        "date": "2026-06-01 08:01:45",
        "description": "Achyut Healthcare Ltd has seen its quality grade improve from below average to average, reflecting nuanced changes in its business fundamentals. While certain metrics such as sales growth and return on equity have shown positive trends, other key indicators like return on capital employed and interest coverage remain concerning. This article analyses the detailed financial parameters behind the recent upgrade and what it means for investors navigating the Pharmaceuticals & Biotechnology micro-cap space."
      },
      {
        "title": "Are Achyut Healthcare Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-achyut-healthcare-ltd-latest-results-good-or-bad-4019001",
        "imagepath": "",
        "date": "2026-05-28 19:27:30",
        "description": "Achyut Healthcare Ltd's latest financial results for Q4 FY26 reveal a complex picture characterized by significant volatility in both revenue and profitability. The company reported net sales of ₹4.39 crores, which reflects a substantial quarter-on-quarter growth of 179.62% compared to ₹1.57 crores in Q3 FY26. However, this follows a notable decline of 38.43% in the previous quarter, indicating erratic sales patterns that may suggest underlying operational instability.\n\nNet profit for the quarter was ₹0.06 crores, a marked increase from ₹0.01 crores in Q3 FY26, representing a dramatic change in profitability. Despite this positive shift, the profit after tax (PAT) margin remained extremely thin at 1.37%, raising concerns about the company's ability to sustain profitability under potential cost pressures. The operating profit margin, excluding other income, was only 0.68%, which is considerably low for the p..."
      },
      {
        "title": "Achyut Healthcare Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/achyut-healthcare-ltd-is-rated-strong-sell-4018079",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AchyutHealthcar_mojoScore_4018079.png",
        "date": "2026-05-28 10:10:04",
        "description": "Achyut Healthcare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 27 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 28 May 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Achyut Healthcare Q4 FY26: Volatile Revenue Masks Persistent Profitability Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/achyut-healthcare-q4-fy26-volatile-revenue-masks-persistent-profitability-concerns-4017949",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AchyutHealthcar_quaterlyResult_4017949.png",
        "date": "2026-05-27 22:32:12",
        "description": "Achyut Healthcare Limited, a micro-cap pharmaceutical company with a market capitalisation of ₹140.00 crores, reported net profit of ₹0.06 crores for Q4 FY26 (quarter ending March 2026), marking a sharp recovery from near-breakeven performance in Q3 FY26. However, the company's wafer-thin profit margins and highly erratic revenue trajectory continue to raise serious questions about operational sustainability. Following the results, the stock declined 1.38% to close at ₹5.70 on May 27, 2026, reflecting investor scepticism about the company's ability to deliver consistent earnings."
      },
      {
        "title": "When is the next results date for Achyut Healthcare Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-achyut-healthcare-ltd-3999806",
        "imagepath": "",
        "date": "2026-05-19 23:19:05",
        "description": "The next results date for Achyut Healthcare Ltd is scheduled for 27 May 2026...."
      }
    ],
    "total": 89,
    "sid": "1003624",
    "stock_news_url": "https://www.marketsmojo.com/news/achyut-healthcare-1003624"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "28-May-2026",
      "details": "Paper Cutting of Published Audited Financial Result for the Quarter and Year ended 31st March 2026",
      "source": "BSE"
    },
    {
      "caption": "Submission Of Statement Of Deviation Or Variation For Proceeds Of Public Issue Pursuant To Regulation 32 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulation 2015 For The Year Ended On 31St March 2026",
      "datetime": "27-May-2026",
      "details": "Submission of Statement of Deviation or Variation for proceeds of public issue pursuant to Regulation 32 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015 for the year ended on 31st March 2026",
      "source": "BSE"
    },
    {
      "caption": "Appointment Of Internal Auditor For The Financial Year 2026-27 Pursuant To Regulation 30 Of The SEBI (LODR) Regulations 2015.",
      "datetime": "27-May-2026",
      "details": "Appointment of Internal Auditor for the Financial Year 2026-27 Pursuant to Regulation 30 of the SEBI (LODR) Regulation 2015.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Achyut Healthcare Ltd has announced <strong>1:10</strong> stock split, ex-date: 10 Dec 24",
          "dt": "2024-12-10",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Achyut Healthcare Ltd has announced <strong>4:10</strong> bonus issue, ex-date: 10 Dec 24",
          "dt": "2024-12-10",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Achyut Healthcare Ltd Upgraded to Sell on Improved Quality and Valuation Concerns

2026-06-01 08:27:02

Achyut Healthcare Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 29 May 2026, reflecting a notable improvement in its quality metrics despite persistent concerns over its valuation and financial trends. The micro-cap pharmaceutical and biotechnology company’s Mojo Score has risen to 35.0, signalling a cautious but more favourable outlook amid mixed fundamentals and technical signals.

Read full news article

Achyut Healthcare Ltd Valuation Shifts Signal Elevated Price Risk

2026-06-01 08:07:15

Achyut Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a marked shift in its valuation parameters, moving from a risky to a very expensive valuation grade. Despite a modest price appreciation, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios have surged well above peer averages and historical norms, raising concerns about price attractiveness for investors.

Read full news article

Achyut Healthcare Ltd Quality Grade Upgrade Signals Improving Fundamentals Amid Mixed Financial Metrics

2026-06-01 08:01:45

Achyut Healthcare Ltd has seen its quality grade improve from below average to average, reflecting nuanced changes in its business fundamentals. While certain metrics such as sales growth and return on equity have shown positive trends, other key indicators like return on capital employed and interest coverage remain concerning. This article analyses the detailed financial parameters behind the recent upgrade and what it means for investors navigating the Pharmaceuticals & Biotechnology micro-cap space.

Read full news article

Are Achyut Healthcare Ltd latest results good or bad?

2026-05-28 19:27:30

Achyut Healthcare Ltd's latest financial results for Q4 FY26 reveal a complex picture characterized by significant volatility in both revenue and profitability. The company reported net sales of ₹4.39 crores, which reflects a substantial quarter-on-quarter growth of 179.62% compared to ₹1.57 crores in Q3 FY26. However, this follows a notable decline of 38.43% in the previous quarter, indicating erratic sales patterns that may suggest underlying operational instability. Net profit for the quarter was ₹0.06 crores, a marked increase from ₹0.01 crores in Q3 FY26, representing a dramatic change in profitability. Despite this positive shift, the profit after tax (PAT) margin remained extremely thin at 1.37%, raising concerns about the company's ability to sustain profitability under potential cost pressures. The operating profit margin, excluding other income, was only 0.68%, which is considerably low for the p...

Read full news article

Achyut Healthcare Ltd is Rated Strong Sell

2026-05-28 10:10:04

Achyut Healthcare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 27 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 28 May 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Achyut Healthcare Q4 FY26: Volatile Revenue Masks Persistent Profitability Concerns

2026-05-27 22:32:12

Achyut Healthcare Limited, a micro-cap pharmaceutical company with a market capitalisation of ₹140.00 crores, reported net profit of ₹0.06 crores for Q4 FY26 (quarter ending March 2026), marking a sharp recovery from near-breakeven performance in Q3 FY26. However, the company's wafer-thin profit margins and highly erratic revenue trajectory continue to raise serious questions about operational sustainability. Following the results, the stock declined 1.38% to close at ₹5.70 on May 27, 2026, reflecting investor scepticism about the company's ability to deliver consistent earnings.

Read full news article

When is the next results date for Achyut Healthcare Ltd?

2026-05-19 23:19:05

The next results date for Achyut Healthcare Ltd is scheduled for 27 May 2026....

Read full news article

View All News